• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Allegion plc

    5/23/25 9:01:14 AM ET
    $ALLE
    Diversified Commercial Services
    Consumer Discretionary
    Get the next $ALLE alert in real time by email
    SD 1 tm2514859d1_sd.htm SD

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM SD

    Specialized Disclosure Report

     

     

     

    ALLEGION PUBLIC LIMITED COMPANY

    (Exact name of registrant as specified in its charter)

     

     

     

    Ireland 001-35971 98-1108930
    (State or other jurisdiction of
    incorporation or organization)
    (Commission File No.) (IRS Employer Identification No.)
         

    Block D

    Iveagh Court

    Harcourt Road

    Dublin 2, Ireland

      D02 VH94
    (Address of principle executive offices)   (Zip code)
         

    Tandra M. Foster

    Deputy General Counsel and Corporate Secretary

    (317) 810-3700

    (Name and telephone number, including area code, of the person to

    contact in connection with this report.)

     

    Check the appropriate box to indicate the rule pursuant to which this form is being filed:

     

    xRule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.

     

    ¨Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended ________.

     

     

     

     

     

     

    Item 1.01 - Conflict Minerals Disclosure and Report

     

    Conflict Minerals Disclosure

     

    The Conflict Minerals Report of Allegion Public Limited Company (the “Company”) for the year ended December 31, 2024 is filed as Exhibit 1.01 to this Form SD.

     

    The Conflict Minerals Report is publicly available at www.allegion.com/corp/en/about/ESG/environmental/conflict-minerals.html. The Company’s website and information accessible through it are not part of, nor incorporated by reference into, this Form SD and the Conflict Minerals Report nor deemed filed with the U.S. Securities and Exchange Commission.

     

    Item 1.02 - Exhibit

     

    The Company’s Conflict Minerals Report for the year ended December 31, 2024 is filed as Exhibit 1.01 to this Form SD.

     

    Item 3.01 - Exhibits

     

    Exhibit   Description
    1.01   Conflict Minerals Report for the Year Ended December 31, 2024

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

     

    ALLEGION PUBLIC LIMITED COMPANY    
    (Registrant)    
         
    /s/ Tandra M. Foster   May 23, 2025
    Tandra M. Foster   (Date)
    Deputy General Counsel & Corporate Secretary    

     

     

     

    Get the next $ALLE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ALLE

    DatePrice TargetRatingAnalyst
    1/6/2025$137.00Equal-Weight
    Morgan Stanley
    6/4/2024$122.00 → $116.00Equal Weight → Underweight
    Barclays
    2/23/2024$140.00 → $141.00Buy → Neutral
    Mizuho
    2/21/2024$139.00 → $140.00Overweight → Equal Weight
    Wells Fargo
    12/4/2023$130.00 → $119.00Overweight → Equal Weight
    Barclays
    10/19/2023$128.00 → $100.00Buy → Hold
    Vertical Research
    9/6/2023Buy → Neutral
    Longbow
    1/3/2023$128.00Hold → Buy
    Vertical Research
    More analyst ratings